KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

From MEIP on the 30th June 2015 page 9: ".....We have acquired,...

  1. Pbnewby
    7,515 Posts.
    lightbulb Created with Sketch. 337
    clock Created with Sketch.
    20/08/16
    09:52
    Post #: 18564164
    From MEIP on the 30th June 2015 page 9:

    ".....We have acquired, by assignment, patents and patent applications from Novogen, our former majority shareholder, which relate to a large family of isoflavonoid compounds, including ME-344. The USPTO has issued two patents covering ME-344, including its composition of matter, pharmaceutical compositions and methods of use to treat cancer. The composition of matter claims covering ME-344 are expected to expire in September 2025, not including patent term extension....."

    http://www.meipharma.com/2015ar/assets/MEI_10K_10-9-2015.pdf
    NRT Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Masson drilling completed - further massive sulphides intercepted
right-arrow Created with Sketch.
NEWS Bonanza grade gold zones discovered – major upside at Western Flanks revealed
right-arrow Created with Sketch.
NEWS Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
right-arrow Created with Sketch.
LU7 Discover the world of North American lithium chemicals with the "Dream Team"
right-arrow Created with Sketch.
NEWS 8000 people have viewed this thread today!
right-arrow Created with Sketch.
NEWS Secured: $3.1M U.S. government contract for high-tech systems – find out what's next
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.